Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1526.HK Stock Summary
In the News
1526.HK Financial details
Company Rating
Strong Buy
Market Cap
1.81B
Income
266.31M
Revenue
4.43B
Book val./share
0.68
Cash/share
0.36
Dividend
0.13
Dividend %
12.44%
Employees
8.98K
Optionable
No
Shortable
Yes
Earnings
30 Aug 2023
P/E
5.71
Forward P/E
-
PEG
-2.39
P/S
0.7
P/B
1.74
P/C
3.19
P/FCF
4.19
Quick Ratio
0.33
Current Ratio
0.63
Debt / Equity
1.05
LT Debt / Equity
0.27
-
-
EPS (TTM)
0.17
EPS next Y
-
EPS next Q
-
EPS this Y
-22.73%
EPS next Y
-
EPS next 5Y
-4.68%
EPS last 5Y
NAN%
Revenue last 5Y
11.57%
Revenue Q/Q
59.64%
EPS Q/Q
-620.81%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
6%
ROE
36%
ROC
0.18%
Gross Margin
39%
Oper. Margin
18%
Profit Margin
12%
Payout
-
Shs Outstand
1.59B
Shs Float
527.49M
-
-
-
-
Target Price
-
52W Range
0.56-1.35
52W High
-
52W Low
-
RSI
50
Rel Volume
0.18
Avg Volume
106.07K
Volume
19K
Perf Week
2.68%
Perf Month
0%
Perf Quarter
26.37%
Perf Half Y
36.9%
-
-
-
-
Beta
0.626
-
-
Volatility
0.01%, 0.02%
Prev Close
1.77%
Price
1.15
Change
9.52%
1526.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.86 | 1.08 | 1.21 | 1.49 | 1.49 | |
Net income per share | -0.03 | -0.04 | 0 | 0.22 | 0.18 | |
Operating cash flow per share | 0.03 | 0.1 | 0.28 | 0.43 | 0.44 | |
Free cash flow per share | -0.16 | -0.09 | 0.05 | 0.22 | 0.25 | |
Cash per share | 0.32 | 0.22 | 0.36 | 0.49 | 0.45 | |
Book value per share | 0.44 | 0.4 | 0.32 | 0.43 | 0.6 | |
Tangible book value per share | 0.43 | 0.34 | 0.2 | 0.36 | 0.57 | |
Share holders equity per share | 0.44 | 0.4 | 0.32 | 0.43 | 0.6 | |
Interest debt per share | 0.5 | 0.89 | 1.14 | 1.05 | 0.83 | |
Market cap | 2.44B | 1.25B | 1.1B | 1.75B | 730.3M | |
Enterprise value | 2.7B | 3.58B | 3.44B | 3.72B | 2.31B | |
P/E ratio | -45.41 | -18.08 | -139.33 | 5.02 | 2.51 | |
Price to sales ratio | 1.78 | 0.72 | 0.57 | 0.74 | 0.31 | |
POCF ratio | 57.34 | 7.58 | 2.47 | 2.57 | 1.03 | |
PFCF ratio | -9.55 | -8.39 | 14.12 | 4.92 | 1.84 | |
P/B Ratio | 3.52 | 1.94 | 2.17 | 2.59 | 0.77 | |
PTB ratio | 3.52 | 1.94 | 2.17 | 2.59 | 0.77 | |
EV to sales | 1.97 | 2.07 | 1.79 | 1.57 | 0.97 | |
Enterprise value over EBITDA | -81.61 | 33.1 | 14.65 | 5.45 | 4.03 | |
EV to operating cash flow | 63.43 | 21.7 | 7.73 | 5.47 | 3.27 | |
EV to free cash flow | -10.57 | -24.04 | 44.25 | 10.45 | 5.83 | |
Earnings yield | -0.02 | -0.06 | -0.01 | 0.2 | 0.4 | |
Free cash flow yield | -0.1 | -0.12 | 0.07 | 0.2 | 0.54 | |
Debt to equity | 1.07 | 1.94 | 3.25 | 2.27 | 1.26 | |
Debt to assets | 0.32 | 0.31 | 0.39 | 0.34 | 0.26 | |
Net debt to EBITDA | -7.85 | 21.54 | 9.97 | 2.89 | 2.76 | |
Current ratio | 0.82 | 0.62 | 0.62 | 0.71 | 0.63 | |
Interest coverage | -3.7 | -0.26 | 0.46 | 4.21 | 3.51 | |
Income quality | -0.79 | -2.39 | -56.45 | 3.75 | 2.43 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.24 | 0.18 | 0.15 | 0.09 | 0.09 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.01 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -7 | -1.9 | -0.83 | -0.48 | -0.44 | |
Capex to revenue | -0.22 | -0.18 | -0.19 | -0.14 | -0.13 | |
Capex to depreciation | -2.45 | -0.9 | -1 | -0.88 | -0.87 | |
Stock based compensation to revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0 | |
Graham number | 0.58 | 0.63 | 0.19 | 1.45 | 1.57 | |
ROIC | -0.13 | -0.01 | 0.02 | 0.11 | 0.09 | |
Return on tangible assets | -0.02 | -0.02 | 0 | 0.08 | 0.06 | |
Graham Net | -0.58 | -1.84 | -1.93 | -1.81 | -1.7 | |
Working capital | -234.31M | -657.52M | -737.67M | -588.35M | -797.54M | |
Tangible asset value | 688.36M | 548.92M | 321.36M | 576.56M | 899.44M | |
Net current asset value | -565.72M | -2.45B | -2.67B | -2.51B | -2.31B | |
Invested capital | 1.07 | 1.94 | 3.25 | 2.27 | 1.26 | |
Average receivables | 232.09M | 279.38M | 286.34M | 314.69M | 312.72M | |
Average payables | 120.75M | 140.14M | 153.62M | 176.42M | 180.13M | |
Average inventory | 32.85M | 47.81M | 52.51M | 56.4M | 58.85M | |
Days sales outstanding | 71.39 | 61.33 | 53.59 | 53.24 | 42.83 | |
Days payables outstanding | 50.47 | 42.23 | 44.39 | 49.28 | 43.1 | |
Days of inventory on hand | 15.42 | 15.83 | 13.88 | 16.05 | 14.13 | |
Receivables turnover | 5.11 | 5.95 | 6.81 | 6.86 | 8.52 | |
Payables turnover | 7.23 | 8.64 | 8.22 | 7.41 | 8.47 | |
Inventory turnover | 23.67 | 23.05 | 26.29 | 22.74 | 25.84 | |
ROE | -0.08 | -0.11 | -0.02 | 0.52 | 0.3 | |
Capex per share | -0.19 | -0.2 | -0.23 | -0.2 | -0.19 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.63 | 0 | 0.51 | 0 | 0.81 | |
Net income per share | 0.01 | 0 | -0.01 | 0 | 0.08 | |
Operating cash flow per share | 0.06 | 0 | 0.04 | 0 | 0.14 | |
Free cash flow per share | -0.02 | 0 | -0.05 | 0 | 0.01 | |
Cash per share | 0.31 | 0 | 0.36 | 0 | 0.36 | |
Book value per share | 0.33 | 0 | 0.34 | 0 | 0.68 | |
Tangible book value per share | 0.18 | 0 | 0.26 | 0 | 0.64 | |
Share holders equity per share | 0.33 | 0 | 0.34 | 0 | 0.68 | |
Interest debt per share | 1.06 | 0 | 0.91 | 0 | 0.71 | |
Market cap | 1.72B | 0 | 1.19B | 0 | 1.37B | |
Enterprise value | 4.14B | 1.97B | 3.27B | 1.58B | 2.97B | |
P/E ratio | 41.14 | 0 | -12.58 | 0 | 2.77 | |
Price to sales ratio | 1.72 | 0 | 1.48 | 0 | 1.06 | |
POCF ratio | 18.61 | 0 | 19.82 | 0 | 6.24 | |
PFCF ratio | -43.96 | 0 | -14.14 | 0 | 120.13 | |
P/B Ratio | 3.29 | 0 | 2.22 | 0 | 1.27 | |
PTB ratio | 3.29 | 0 | 2.22 | 0 | 1.27 | |
EV to sales | 4.14 | 0 | 4.06 | 0 | 2.31 | |
Enterprise value over EBITDA | 25.86 | 0 | 75.1 | 0 | 9.55 | |
EV to operating cash flow | 44.74 | 0 | 54.26 | 0 | 13.56 | |
EV to free cash flow | -105.66 | 0 | -38.7 | 0 | 261.03 | |
Earnings yield | 0.01 | 0 | -0.02 | 0 | 0.09 | |
Free cash flow yield | -0.02 | 0 | -0.07 | 0 | 0.01 | |
Debt to equity | 3.22 | 2.27 | 2.69 | 1.26 | 1.05 | |
Debt to assets | 0.4 | 0.34 | 0.35 | 0.26 | 0.27 | |
Net debt to EBITDA | 15.1 | 0 | 47.66 | 0 | 5.16 | |
Current ratio | 0.57 | 0.71 | 0.57 | 0.63 | 0.55 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 8.84 | 0 | -0.51 | 0 | 1.78 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.11 | 0 | 0.12 | 0 | 0.08 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.42 | 0 | -2.4 | 0 | -0.95 | |
Capex to revenue | -0.13 | 0 | -0.18 | 0 | -0.16 | |
Capex to depreciation | -0.71 | 0 | -0.73 | 0 | -1.08 | |
Stock based compensation to revenue | 0.01 | 0 | 0.01 | 0 | 0 | |
Graham number | 0.22 | 0 | 0.34 | 0 | 1.09 | |
ROIC | 0.14 | 0 | -0.02 | 0 | 0.05 | |
Return on tangible assets | 0 | 0 | -0.01 | 0 | 0.03 | |
Graham Net | -1.96 | 0 | -1.88 | 0 | -1.54 | |
Working capital | -830.57M | -588.35M | -847.75M | -797.54M | -827.17M | |
Tangible asset value | 291.25M | 576.56M | 419.53M | 899.44M | 1.02B | |
Net current asset value | -2.77B | -2.51B | -2.63B | -2.31B | -2.23B | |
Invested capital | 3.22 | 2.27 | 2.69 | 1.26 | 1.05 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 26.01 | 0 | 23.46 | 0 | 17.2 | |
Days payables outstanding | 23.02 | 0 | 26.67 | 0 | 15.42 | |
Days of inventory on hand | 6.83 | 0 | 8.51 | 0 | 5.58 | |
Receivables turnover | 3.46 | 0 | 3.84 | 0 | 5.23 | |
Payables turnover | 3.91 | 0 | 3.37 | 0 | 5.84 | |
Inventory turnover | 13.18 | 0 | 10.57 | 0 | 16.14 | |
ROE | 0.02 | 0 | -0.04 | 0 | 0.11 | |
Capex per share | -0.08 | 0 | -0.09 | 0 | -0.13 |
1526.HK Frequently Asked Questions
What is Rici Healthcare Holdings Limited stock symbol ?
Rici Healthcare Holdings Limited is a CN stock and trading under the symbol 1526.HK
What is Rici Healthcare Holdings Limited stock quote today ?
Rici Healthcare Holdings Limited stock price is $1.15 today.
Is Rici Healthcare Holdings Limited stock public?
Yes, Rici Healthcare Holdings Limited is a publicly traded company.